Promoter methylation of MGMT gene in serum of patients with esophageal squamous cell carcinoma in North East India

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 22, 2014, Pages 9955-9960

  Das, Mandakini ^a   Sharma, Santanu Kumar ^a   Sekhon, Gaganpreet Singh ^a   Saikia, Bhaskar Jyoti ^a   Mahanta, Jagadish ^a   Phukan, Rup Kumar ^a  

^a REGIONAL MEDICAL RESEARCH CENTRE   (India)

Author keywords

Biomarker; Esophageal cancer; Methylation; MGMT; North East India

Indexed keywords

DNA METHYLTRANSFERASE; MGMT PROTEIN, HUMAN; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; TUMOR MARKER; TUMOR SUPPRESSOR PROTEIN;

ADULT; AGED; BLOOD; CANCER STAGING; CASE CONTROL STUDY; COMPARATIVE STUDY; DNA METHYLATION; ESOPHAGUS TUMOR; FEMALE; FOLLOW UP; GENETICS; HUMAN; INDIA; MALE; MIDDLE AGED; PATHOLOGY; PROGNOSIS; PROMOTER REGION; RISK FACTOR; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; DNA METHYLATION; DNA MODIFICATION METHYLASES; DNA REPAIR ENZYMES; ESOPHAGEAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INDIA; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROMOTER REGIONS, GENETIC; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 84921505529     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.22.9955     Document Type: Article

References (31)

1. Baumann S, Keller G, Puhringer F, et al (2006). The prognostic impact of O6-Methylguanine-DNA Methyltransferase (MGMT) promotor hypermethylation in esophageal adenocarcinoma. Int J Cancer, 119, 264-8.
2. Chattopadhyay I, Kapur S, Purkayastha J, et al (2007). Gene expression profile of esophageal cancer in North East India by cDNA microarray analysis. World J Gastroenterol, 13, 1438-44.
3. Chen J, Huang ZJ, Duan YQ, et al (2012). Aberrant DNA methylation of P16, MGMT, and hMLH1 genes in combination with MTHFR C677T genetic polymorphism and folate intake in esophageal squamous cell carcinoma. Asian Pac J Cancer Prev, 13, 5303-6.
4. Corvalan AH, Maturana MJ (2010). Recent patents of DNA methylation biomarkers in gastrointestinal oncology. Recent Pat DNA Gene Seq, 4, 202-9.
5. Du L, Wang H, Xiong T, et al (2013). The polymorphisms in the MGMT gene and the risk of cancer: a meta-analysis. Tumour Biol, 34, 3227-37.
6. Fang MZ, Jin Z, Wang Y, et al (2005). Promoter hypermethylation and inactivation of O(6)-methylguanine-DNA methyltransferase in esophageal squamous cell carcinomas and its reactivation in cell lines. Int J Oncol, 26, 615-22.
7. Ferlay J, Soerjomataram I, Ervik M, et al (2012). GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer. [11 July; 2014] Available from: http://globocan.iarc.fr.
8. Gao S, Ding LH, Wang JW, et al (2013). Diet folate, DNA methylation and polymorphisms in methylenetetrahydrofolate reductase in association with the susceptibility to gastric cancer. Asian Pac J Cancer Prev, 14, 299-302.
9. Herman JG, Baylin SB (2001). Methylation-specific PCR. Current protocols in human genetics/editorial board, Jonathan L Haines [et al] Chapter 10, Unit 10-16.
10. Katayama H, Hiraki A, Fujiwara K, et al (2007). Aberrant promoter methylation profile in pleural fluid DNA and clinicopathological factors in patients with non-small cell lung cancer. Asian Pac J Cancer Prev, 8, 221-4.
11. Khatami F, Noorinayer B, Mohebi SR, et al (2009). Effects of amino acid substitution polymorphisms of two DNA methyltransferases on susceptibility to sporadic colorectal cancer. Asian Pac J Cancer Prev, 10, 1183-8.
12. Larijani L, Madjd Z, Samadikuchaksaraei A, et al (2014). Methylation of O6-methyl guanine methyltransferase gene promoter in meningiomas-comparison between tumor grades I, II, and III. Asian Pac J Cancer Prev, 15, 33-8.
13. Limpaiboon T (2012). Epigenetic aberrations in cholangiocarcinoma: potential biomarkers and promising target for novel therapeutic strategies. Asian Pac J Cancer Prev, 13, 41-5.
14. Lin RK HY, Lin P, Hsu HS, Chen CY, Tang YA et al. (2010). The tobacco-specific carcinogen NNK induces DNA methyltransferase 1 accumulation and tumor suppressor gene hypermethylation in mice and lung cancer patients. J Clin Invest, 120, 521-32.
15. Liu JF, Xie HJ, Cheng TM (2013). Lack of any association between insertion/deletion (I/D) polymorphisms in the angiotensin-converting enzyme gene and digestive system cancer risk: a meta-analysis. Asian Pac J Cancer Prev, 14, 7271-5.
16. National Cancer Registry Programme (NCRP) (2010). Three-year report of the population based cancer registries 2006-2008. (First report of 20 PBCRs in India), Bangalore, India. Indian Council Med Res, 11, 70-90.
17. National Cancer Registry Programme (NCRP) (2013). Three-year report of the population based cancer registries 2009-2011, (Incidence and Distribution of Cancer: Report of 25 PBCRs in India), Bangalore, India. Indian Council Med Res, 7, 154-79.
18. Phukan RK, Ali MS, Chetia CK, Mahanta J (2001a). Betel nut and tobacco chewing; potential risk factors of cancer of oesophagus in Assam, India. Br J Cancer, 85, 661-7.
19. Phukan RK, Chetia CK, Ali MS, Mahanta J (2001b). Role of dietary habits in the development of esophageal cancer in Assam, the north-eastern region of India. Nutr Cancer, 39, 204-9.
20. Phukan RK, Zomawia E, Narain K, Hazarika NC, Mahanta J (2005). Tobacco use and stomach cancer in Mizoram, India. Cancer Epidemiol Biomarkers Prev, 14, 1892-6.
21. Phukan RK, Narain K, Zomawia E, Hazarika NC, Mahanta J (2006). Dietary habits and stomach cancer in Mizoram, India. J Gastroenterol, 41, 418-24.
22. Phukan RK, Saikia BJ, Borah PK, et al (2014). Role of household exposure, dietary habits and glutathione s-transferases M1, T1 polymorphisms in susceptibility to lung cancer among women in Mizoram India. Asian Pac J Cancer Prev, 15, 3253-60.
23. Saikia BJ, Phukan RK, Sharma SK, Sekhon GS, Mahanta J (2014). Interaction of XRCC1 and XPD Gene Polymorphisms with Lifestyle and Environmental Factors Regarding Susceptibility to Lung Cancer in a High Incidence Population in North East India. Asian Pac J Cancer Prev, 15, 1993-9.
24. Sharma A, Das BC, Sehgal A, et al (2013). GSTM1 and GSTT1 polymorphism and susceptibility to esophageal cancer in high-and low-risk regions of India. Tumour Biol, 34, 3249-57.
25. Sharma JD, Kalita M, Barbhuiya JA, et al (2014a). Descriptive report on pattern of variation in cancer cases within selected ethnic groups in Kamrup Urban District of Assam, 2009-2011. Asian Pac J Cancer Prev, 15, 6381-6.
26. Sharma JD, Kalita M, Nirmolia T, et al (2014b). Cancer: scenario and relationship of different geographical areas of the globe with special reference to North East-India. Asian Pac J Cancer Prev, 15, 3721-9.
27. Talukdar FR, Ghosh SK, Laskar RS, et al (2013). Epigenetic, genetic and environmental interactions in esophageal squamous cell carcinoma from northeast India. PLoS One, 8, 60996.
28. Wang J, Sasco AJ, Fu C, et al (2008). Aberrant DNA methylation of P16, MGMT, and hMLH1 genes in combination with MTHFR C677T genetic polymorphism in esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev, 17, 118-25.
29. Xiong HL, Liu XQ, Sun AH, et al (2013). Aberrant DNA methylation of P16, MGMT, hMLH1 and hMSH2 genes in combination with the MTHFR C677T genetic polymorphism in gastric cancer. Asian Pac J Cancer Prev, 14, 3139-42.
30. Ye C, Shrubsole MJ, Cai Q, et al (2006). Promoter methylation status of the MGMT, hMLH1, and CDKN2A/p16 genes in non-neoplastic mucosa of patients with and without colorectal adenomas. Oncol Rep, 16, 429-35.
31. Zhang L, Lu W, Miao X, et al (2003). Inactivation of DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation and its relation to p53 mutations in esophageal squamous cell carcinoma. Carcinogenesis, 24, 1039-44.